lobbying_activities: 2904504
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
This data as json
| id | filing_uuid | filing_type | registrant_name | registrant_id | client_name | filing_year | filing_period | issue_code | specific_issues | government_entities | is_no_activity | is_termination | received_date |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2904504 | 21117108-91c7-4cdc-9dc9-5cf7d887abc4 | 4T | AVANIR PHARMACEUTICALS | 401103474 | AVANIR PHARMACEUTICALS | 2022 | fourth_quarter | HCR | H.R.7667 - Food and Drug Amendments of 2022, specifically provisions regarding the Prescription Drug User Fee Act (PDUFA). H.R.5376 - Inflation Reduction Act of 2022, specifically provisions relating to prescription drug pricing. Issues related to mental health. | HOUSE OF REPRESENTATIVES,SENATE | 0 | 1 | 2022-11-22T09:03:47-05:00 |